the antihypertensive , humoral , and renal effects of acute single oral administration of placebo and isradipine , a new dihydropyridine calcium antagonist , at doses of 2.5 mg , 5.0 mg , and 7.5 mg once daily were investigated in 11 patients with mild-to-moderate uncomplicated essential hypertension .
C0071304
isradipine
C2945601
dihydropyridine calcium